Abstract:Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third leading cause of cancer‐related death worldwide. HCC exhibits strong inter‐tumor heterogeneity, with different biological characteristics closely associated with prognosis. In addition, patients with HCC often distribute at different stages and require diverse treatment options at each stage. Due to the variability in tumor sensitivity to different therapies, determining the optimal treatment approach can be challenging for clinicians prior to treatment. Artificial intelligence (AI) technology, including radiomics and deep learning approaches, has emerged as a unique opportunity to improve the spectrum of HCC clinical care by predicting biological characteristics and prognosis in the medical imaging field. The radiomics approach utilizes handcrafted features derived from specific mathematical formulas to construct various machine‐learning models for medical applications. In terms of the deep learning approach, convolutional neural network models are developed to achieve high classification performance based on automatic feature extraction from images. Magnetic resonance imaging offers the advantage of superior tissue resolution and functional information. This comprehensive evaluation plays a vital role in the accurate assessment and effective treatment planning for HCC patients. Recent studies have applied radiomics and deep learning approaches to develop AI‐enabled models to improve accuracy in predicting biological characteristics and prognosis, such as microvascular invasion and tumor recurrence. Although AI‐enabled models have demonstrated promising potential in HCC with biological characteristics and prognosis prediction with high performance, one of the biggest challenges, interpretability, has hindered their implementation in clinical practice. In the future, continued research is needed to improve the interpretability of AI‐enabled models, including aspects such as domain knowledge, novel algorithms, and multi‐dimension data sources. Overcoming these challenges would allow AI‐enabled models to significantly impact the care provided to HCC patients, ultimately leading to their deployment for clinical use. Level of Evidence 5 Technical Efficacy Stage 2

Role of noninvasive imaging in the evaluation of intrahepatic cholangiocarcinoma: from diagnosis and prognosis to treatment response.

Radiomics Analysis of Contrast-Enhanced CT for the Preoperative Prediction of Microvascular Invasion in Mass-Forming Intrahepatic Cholangiocarcinoma

Radiomics in the Diagnosis and Treatment of Hepatocellular Carcinoma

Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: Application and development trend

Advances in Radiomics Applications for Intrahepatic Cholangiocarcinoma: a Comprehensive Review and Future Directions

Update on the Applications of Radiomics in Diagnosis, Staging, and Recurrence of Intrahepatic Cholangiocarcinoma

Preoperative Ultrasound Radiomics Signatures for Noninvasive Evaluation of Biological Characteristics of Intrahepatic Cholangiocarcinoma

Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma

Imaging features based on CT and MRI for predicting prognosis of patients with intrahepatic cholangiocarcinoma: a single-center study and meta-analysis

Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis.

A nomogram based on radiomics to predict microvascular invasion and overall survival in intrahepatic cholangiocarcinoma

Integrating Pathomics and Radiomics for Predicting Survival among Patients with Intrahepatic Cholangiocarcinoma Undergoing Surgical Resection.

Machine Learning: an Approach to Preoperatively Predict PD-1/PD-L1 Expression and Outcome in Intrahepatic Cholangiocarcinoma Using MRI Biomarkers.

Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study

Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma

Development and Validation of Combined Ki67 Status Prediction Model for Intrahepatic Cholangiocarcinoma Based on Clinicoradiological Features and MRI Radiomics

Research progress in the diagnosis and treatment of intrahepatic cholangiocellular carcinoma

MRI‐Based Radiomics and Deep Learning in Biological Characteristics and Prognosis of Hepatocellular Carcinoma: Opportunities and Challenges

Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma.

Immunotherapy and Targeted Therapy for Cholangiocarcinoma: Artificial Intelligence Research in Imaging

Multi-omics-driven Discovery of Invasive Patterns and Treatment Strategies in CA19-9 Positive Intrahepatic Cholangiocarcinoma